Synthesis of imatinib: a convergent approach revisited

A classical convergent approach for the synthesis of the anticancer drug imatinib has been substantially improved. Imatinib was assembled by coupling the amine and carboxylic acid precursors by using N, N'-carbonyldi-imidazole (CDI) as a condensing agent. Both intermediates have been synthesized by novel efficient methods.